Vascular endothelial growth factor inhibits bone morphogenetic protein 2 expression in rat mesenchymal stem cells

Tissue Engineering - Part A

Volumn 16, Issue 2, 2010, Pages 653-662

  Schönmeyr, Björn H ^a   Soares, Marc ^a   Avraham, Tomer ^a   Clavin, Nicholas W ^a   Gewalli, Fredrik ^a   Mehrara, Babak J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; CELL CULTURE; ENDOTHELIAL CELLS; EXPERIMENTS; FLOWCHARTING; NUCLEIC ACIDS; PEPTIDES; SELF ASSEMBLY; STEM CELLS; TISSUE ENGINEERING; TRANSCRIPTION;

BONE FORMATION; BONE MORPHOGENETIC PROTEIN-2; BONE MORPHOGENETIC PROTEINS; BONE TISSUE ENGINEERING; CO-TRANSFECTIONS; COCULTURE; ECTOPIC BONES; GROWTH FACTOR; IN-VITRO; IN-VIVO; MESENCHYMAL STEM CELL; MRNA EXPRESSION; OSTEOGENESIS; OVER-EXPRESSION; PARACRINE; POTENT INHIBITOR; POTENTIAL MECHANISM; PROTEIN EXPRESSIONS; PROTEIN PRODUCTION; TRANS-GENES; TRANSCRIPTIONAL LEVELS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

BONE;

ADENOVIRIDAE; RATTUS;

BONE MORPHOGENETIC PROTEIN 2; VASCULOTROPIN A;

ADENOVIRUS; ANIMAL; ARTICLE; AUTOCRINE EFFECT; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; HUMAN; LEWIS RAT; MESENCHYMAL STEM CELL; METABOLISM; MOUSE; PARACRINE SIGNALING; RAT;

ADENOVIRIDAE; ANIMALS; AUTOCRINE COMMUNICATION; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMANS; MESENCHYMAL STEM CELLS; MICE; OSTEOGENESIS; PARACRINE COMMUNICATION; RATS; RATS, INBRED LEW; TRANSCRIPTION, GENETIC; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77049105233     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0426     Document Type: Conference Paper

References (36)

1. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
2. Huss, F.R., and Kratz, G. Mammary epithelial cell and adi-pocyte co-culture in a 3-D matrix: the first step towards tissue-engineered human breast tissue. Cells Tissues Organs 169, 361, 2001.
3. Baker, B.M., and Mauck, R.L. The effect of nanofiber alignment on the maturation of engineered meniscus constructs. Biomaterials 28, 1967, 2007.
4. Hoerstrup, S.P., Kadner, A., Melnitchouk, S., Trojan, A., Eid, K., Tracy, J., Sodian, R., Visjager, J.F., Kolb, S.A., Gru-nenfelder, J., Zund, G., and Turina, M.I. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation 106, I143, 2002.
5. Yang, D., Guo, T., Nie, C., and Morris, S.F. Tissue-engineered blood vessel graft produced by self-derived cells and allogenic acellular matrix: a functional performance and histologic study. Ann Plast Surg 62, 297, 2009.
6. Alhadlaq, A., and Mao, J.J. Tissue-engineered osteochondral constructs in the shape of an articular condyle. J Bone Joint Surg Am 87, 936, 2005.
7. Liu, P., Deng, Z., Han, S., Liu, T., Wen, N., Lu, W., Geng, X., Huang, S., and Jin, Y. Tissue-engineered skin containing mesenchymal stem cells improves burn wounds. Artif Organs 32, 925, 2008.
8. Yamasaki, T., Deie, M., Shinomiya, R., Yasunaga, Y., Yanada, S., and Ochi, M. Transplantation of meniscus regenerated by tissue engineering with a scaffold derived from a rat meniscus and mesenchymal stromal cells derived from rat bone marrow. Artif Organs 32, 519, 2008.
9. Wu, B., Zheng, Q., Guo, X., Wu, Y., Wang, Y., and Cui, F. Preparation and ectopic osteogenesis in vivo of scaffold based on mineralized recombinant human-like collagen loaded with synthetic BMP-2-derived peptide. Biomed Mater 3, 44111, 2008.
10. Oliveira, S.M., Amaral, I.F., Barbosa, M.A., and Teixeira, C.C. Engineering endochondral bone: in vitro studies. Tissue Eng Part A 15, 625, 2009.
11. Oda, M., Kuroda, S., Konda, H., and Kasugai, S. Hydro-xyapatite fiber material with BMP-2 gene induces ectopic bone formation. J Biomed Mater Res B Appl Biomater 90, 101, 2009.
12. Lee, D.H., Park, B.J., Lee, M.S., Lee, J.W., Kim, J.K., Yang, H.C., and Park, J.C. Chemotactic migration of human mes-enchymal stem cells and MC3T3-E1 osteoblast-like cells induced by COS-7 cell line expressing rhBMP-7. Tissue Eng 12, 1577, 2006.
13. Minamide, A., Tamaki, T., Kawakami, M., Hashizume, H., Yoshida, M., and Sakata, R. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2. Spine 24, 1863-1870; discussion 71-72, 1999.
14. Sheehan, J.P., Sheehan, J.M., Seeherman, H., Quigg, M., and Helm, G.A. The safety and utility of recombinant human bone morphogenetic protein-2 for cranial procedures in a nonhuman primate model. J Neurosurg 98, 125, 2003.
15. Nilsson, O.S., Urist, M.R., Dawson, E.G., Schmalzried, T.P., and Finerman, G.A. Bone repair induced by bone morpho-genetic protein in ulnar defects in dogs. J Bone Joint Surg Br 68, 635, 1986.
16. Peterson, B., Zhang, J., Iglesias, R., Kabo, M., Hedrick, M., Benhaim, P., and Lieberman, J.R. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng 11, 120, 2005.
17. Maes, C., Carmeliet, P., Moermans, K., Stockmans, I., Smets, N., Collen, D., Bouillon, R., and Carmeliet, G. Impaired an-giogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech Dev 111, 61, 2002.
18. Peng, H., Usas, A., Olshanski, A., Ho, A.M., Gearhart, B., Cooper, G.M., and Huard, J. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 20, 2017, 2005.
19. Peng, H., Wright, V., Usas, A., Gearhart, B., Shen, H.C., Cummins, J., and Huard, J. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110, 751, 2002.
20. Zelzer, E., and Olsen, B.R. Multiple roles of vascular endo-thelial growth factor (VEGF) in skeletal development, growth, and repair. Curr Top Dev Biol 65, 169, 2005.
21. Lohela, M., Bry, M., Tammela, T., and Alitalo, K. VEGFs and receptors involved in angiogenesis versus lymphangiogen-esis. Curr Opin Cell Biol 21, 154, 2009.
22. Okuyama, H., Krishnamachary, B., Zhou, Y.F., Nagasawa, H., Bosch-Marce, M., and Semenza, G.L. Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-induc-ible factor 1. J Biol Chem 281, 15554, 2006.
23. Mehrara, B.J., Saadeh, P.B., Steinbrech, D.S., Dudziak, M., Spector, J.A., Greenwald, J.A., Gittes, G.K., and Longaker, M.T. Adenovirus-mediated gene therapy of osteoblasts in vitro and in vivo. J Bone Miner Res 14, 1290, 1999.
24. Feng, J.Q., Harris, M.A., Ghosh-Choudhury, N., Feng, M., Mundy, G.R., and Harris, S.E. Structure and sequence of mouse bone morphogenetic protein-2 gene (BMP-2): comparison of the structures and promoter regions of BMP-2 and BMP-4 genes. Biochim Biophys Acta 1218, 221, 1994.
25. Clauss, M., Gerlach, M., Gerlach, H., Brett, J., Wang, F., Familletti, P.C., Pan, Y.C., Olander, J.V., Connolly, D.T., and Stern, D. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172, 1535, 1990.
26. Senger, D.R., Connolly, D.T., Van de Water, L., Feder, J., and Dvorak, H.F. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 50, 1774, 1990.
27. Senger, D.R., Perruzzi, C.A., Feder, J., and Dvorak, H.F. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46, 5629, 1986.
28. Li, G., Corsi-Payne, K., Zheng, B., Usas, A., Peng, H., and Huard, J. The dose of growth factors influences the syner-gistic effect of vascular endothelial growth factor on bone morphogenetic protein 4-induced ectopic bone formation. Tissue Eng Part A 15, 2123, 2009.
29. Geiger, F., Lorenz, H., Xu, W., Szalay, K., Kasten, P., Claes, L., Augat, P., and Richter, W. VEGF producing bone marrow stromal cells (BMSC) enhance vascularization and resorp-tion of a natural coral bone substitute. Bone 41, 516, 2007.
30. Patel, Z.S., Young, S., Tabata, Y., Jansen, J.A., Wong, M.E., and Mikos, A.G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 43, 931, 2008.
31. Hayami, T., Funaki, H., Yaoeda, K., Mitui, K., Yamagiwa, H., Tokunaga, K., Hatano, H., Kondo, J., Hiraki, Y., Yama-moto, T., Duong le, T., and Endo, N. Expression of the cartilage derived anti-angiogenic factor chondromodulin-I decreases in the early stage of experimental osteoarthritis. J Rheumatol 30, 2207, 2003.
32. Moses, M.A., Sudhalter, J., and Langer, R. Identification of an inhibitor of neovascularization from cartilage. Science 248, 1408, 1990.
33. Wedge, S.R., Ogilvie, D.J., Dukes, M., Kendrew, J., Chester, R., Jackson, J.A., Boffey, S.J., Valentine, P.J., Curwen, J.O., Musgrove, H.L., Graham, G.A., Hughes, G.D., Thomas, A.P., Stokes, E.S., Curry, B., Richmond, G.H., Wadsworth, P.F., Bigley, A.L., and Hennequin, L.F. ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration. Cancer Res 62, 4645, 2002.
34. Oswald, J., Boxberger, S., Jorgensen, B., Feldmann, S., Eh-ninger, G., Bornhauser, M., and Werner, C. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22, 377, 2004.
35. Gerber, H.P., Vu, T.H., Ryan, A.M., Kowalski, J., Werb, Z., and Ferrara, N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochon-dral bone formation. Nat Med 5, 623, 1999.
36. Kuhnert, F., Mancuso, M.R., Hampton, J., Stankunas, K., Asano, T., Chen, C.Z., and Kuo, C.J. Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development 135, 3989, 2008.